Respiratory General Practice Strong — GOLD 2023 / Jones 2009
COPD Assessment Test (CAT)
8-item patient-reported outcome measure quantifying COPD symptom impact on daily life. Validated for GOLD ABCD grouping.
References
- Jones PW et al. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009.
- GOLD 2023 Global Strategy for Prevention, Diagnosis and Management of COPD.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Tetracosactide · Synthetic ACTH (short Synacthen test)
- Urea (13C) · 13C-urea breath test
- Factor IX Concentrate · Coagulation Factor Replacement — Haemophilia B
- Azithromycin (COPD Exacerbation Prophylaxis) · Macrolide antibiotic (anti-inflammatory / prophylactic)
- Doxycycline (COPD Exacerbation / CAP) · Oral tetracycline antibiotic
- Co-amoxiclav 625mg (COPD Exacerbation / CAP) · Beta-lactam / Beta-lactamase inhibitor combination antibiotic
Pathways
- Acute Asthma in Adults · BTS/SIGN British Guideline on Asthma 2019; NICE NG80
- Pulmonary Embolism Assessment · NICE NG158; ESC 2019 PE Guidelines
- COPD Exacerbation Management · NICE NG115 / GOLD 2024
- Community-Acquired Pneumonia (CURB-65) · BTS 2009 / NICE NG138
- Acute Pulmonary Embolism · BTS 2003 / ESC 2019
- Pleural Effusion Assessment · BTS 2010
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.